Literature DB >> 9105697

Effects of levcromakalim and nucleoside diphosphates on glibenclamide-sensitive K+ channels in pig urethral myocytes.

N Teramoto1, G McMurray, A F Brading.   

Abstract

1. Effects of levcromakalim and nucleoside diphosphates (NDPs) on both membrane currents and unitary currents in pig proximal urethra were investigated by use of patch clamp techniques (conventional whole-cell configuration, nystatin perforated patch, cell-attached configuration and inside-out patches). 2. Levcromakalim produced a concentration-dependent outward current at a holding potential of -50 mV. The peak current amplitude showed little variation when measured by either conventional whole-cell or nystatin perforated patch configurations. 3. In conventional whole-cell configuration, the levcromakalim (100 microM)-induced outward current decayed by about 90% in 18 min. In contrast, with the nystatin perforated patch, approximately 86% of the levcromakalim-induced outward current still remained after 18 min. 4. The peak amplitude of the levcromakalim (100 microM)-induced outward membrane current recorded by the conventional whole-cell configuration was greatly reduced by inclusion of 5 mM EDTA in the pipette. The much smaller but significant outward membrane current remaining was abolished by glibenclamide. 5. In conventional whole-cell recordings, inclusion of an NDP in the pipette solution induced a small outward current which slowly reached a maximal amplitude (in 2 to 10 min) and was suppressed by glibenclamide. Addition of 100 microM levcromakalim after the NDP-induced current had peaked activated a further outward current which was larger than that recorded in the absence of NDPs. Approximately 50% of this current still remained at 18 min, even when conventional whole-cell configuration was used. 6. In the cell-attached mode in symmetrical 140 mM K+ conditions, glibenclamide inhibited the 100 microM levcromakalim-activated 43 pS K+ channel in a concentration-dependent manner, showing an inhibitory dissociation constant (Ki) of approximately 520 nM. 7. In inside-out patches in which the glibenclamide-sensitive K+ channel had run down after exposure to levcromakalim, both uridine 5'-diphosphate (UDP) and MgATP were capable of reactivating the channel. Further application of Mg2+ to the UDP-reactivated K+ channels enhanced the channel activity reversibly. 8. In inside-out patches UDP was capable of activating the glibenclamide-sensitive K+ channel without levcromakalim, providing that there was free Mg2+ present (either UDP in 5 mM EGTA or UDP in 5 mM EDTA with Mg2+). Additional application of levcromakalim caused a further reversible activation of channel opening. 9. In the presence of levcromakalim, application of adenosine 5'-triphosphate (ATP) to the inner surface of the membrane patch inhibited UDP-reactivated channel opening in a concentration-dependent manner. 10. Addition of an untreated cytosolic extract of pig proximal urethra reactivated the glibenclamide-sensitive K+ channel in the presence of 100 microM levcromakalim in inside-out patches. 11. These results demonstrate the presence in the pig proximal urethra of a glibenclamide-sensitive K+ channel that is blocked by intracellular ATP and can be activated by levcromakalim. Intracellular UDP can reactivate the channel after rundown. Additionally, intracellular Mg2+ may play an important role in regulating the channel activity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9105697      PMCID: PMC1564596          DOI: 10.1038/sj.bjp.0701033

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  12 in total

1.  Dual action of ZD6169, a novel K(+) channel opener, on ATP-sensitive K(+) channels in pig urethral myocytes.

Authors:  N Teramoto; T Yunoki; M Takano; Y Yonemitsu; I Masaki; K Sueishi; A F Brading; Y Ito
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

2.  Properties and pharmacological modification of ATP-sensitive K(+) channels in cat tracheal myocytes.

Authors:  N Teramoto; T Nakashima; Y Ito
Journal:  Br J Pharmacol       Date:  2000-06       Impact factor: 8.739

Review 3.  Muscle KATP channels: recent insights to energy sensing and myoprotection.

Authors:  Thomas P Flagg; Decha Enkvetchakul; Joseph C Koster; Colin G Nichols
Journal:  Physiol Rev       Date:  2010-07       Impact factor: 37.312

4.  Expression of ATP-sensitive potassium channels in human pregnant myometrium.

Authors:  Chen Xu; Xingji You; Lu Gao; Lanmei Zhang; Rong Hu; Ning Hui; David M Olson; Xin Ni
Journal:  Reprod Biol Endocrinol       Date:  2011-03-21       Impact factor: 5.211

5.  Ex vivo biomechanical, functional, and immunohistochemical alterations of adrenergic responses in the female urethra in a rat model of birth trauma.

Authors:  Rachelle Prantil-Baun; William C de Groat; Minoru Miyazato; Michael B Chancellor; Naoki Yoshimura; David A Vorp
Journal:  Am J Physiol Renal Physiol       Date:  2010-05-05

6.  Pharmacological evidence for a KATP channel in renin-secreting cells from rat kidney.

Authors:  U Russ; U Rauch; U Quast
Journal:  J Physiol       Date:  1999-06-15       Impact factor: 5.182

7.  Characterization of an ATP-sensitive K(+) channel in rat carotid body glomus cells.

Authors:  Donghee Kim; Insook Kim; Justin R Papreck; David F Donnelly; John L Carroll
Journal:  Respir Physiol Neurobiol       Date:  2011-04-22       Impact factor: 1.931

8.  The effects of caffeine on ATP-sensitive K(+) channels in smooth muscle cells from pig urethra.

Authors:  N Teramoto; T Yunoki; K Tanaka; M Takano; I Masaki; Y Yonemitsu; K Sueishi; Y Ito
Journal:  Br J Pharmacol       Date:  2000-10       Impact factor: 8.739

Review 9.  Molecular biology of K(ATP) channels and implications for health and disease.

Authors:  Alejandro Akrouh; S Eliza Halcomb; Colin G Nichols; Monica Sala-Rabanal
Journal:  IUBMB Life       Date:  2009-10       Impact factor: 3.885

Review 10.  Physiological roles of ATP-sensitive K+ channels in smooth muscle.

Authors:  Noriyoshi Teramoto
Journal:  J Physiol       Date:  2006-05-01       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.